- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Ascendis Pharma
Market Cap: US$14.2b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$228.06
7D
-5.2%
1Y
38.5%
Madrigal Pharmaceuticals
Market Cap: US$10.1b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$443.18
7D
2.4%
1Y
30.9%
Insmed
Market Cap: US$31.2b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$143.93
7D
0.06%
1Y
86.9%
Alnylam Pharmaceuticals
Market Cap: US$42.3b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$320.42
7D
-0.6%
1Y
31.2%
BeOne Medicines
Market Cap: US$32.1b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$287.33
7D
-5.9%
1Y
9.9%
BridgeBio Pharma
Market Cap: US$13.8b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$70.94
7D
-4.5%
1Y
120.4%
Ionis Pharmaceuticals
Market Cap: US$11.9b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$72.33
7D
-4.4%
1Y
119.5%
AbbVie
Market Cap: US$391.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$219.76
7D
-3.2%
1Y
2.8%
Jazz Pharmaceuticals
Market Cap: US$11.2b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$181.37
7D
-2.5%
1Y
30.0%
Eli Lilly
Market Cap: US$883.6b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$930.35
7D
-7.1%
1Y
13.1%
BioMarin Pharmaceutical
Market Cap: US$11.0b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$56.05
7D
-7.9%
1Y
-21.6%
Natera
Market Cap: US$28.0b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$198.38
7D
-0.3%
1Y
35.6%
Viatris
Market Cap: US$15.6b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$13.80
7D
-2.0%
1Y
45.0%
Royalty Pharma
Market Cap: US$26.6b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$46.11
7D
0.3%
1Y
38.0%
Exact Sciences
Market Cap: US$19.8b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$103.94
7D
0.6%
1Y
131.4%
Elanco Animal Health
Market Cap: US$11.6b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$25.18
7D
6.4%
1Y
132.9%
Waters
Market Cap: US$28.5b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$296.99
7D
-0.9%
1Y
-22.3%